Adaptive Biotechnologies Corp

Biotechnology

Based in WA

🤖

AI Overview

With $10K in lobbying spend across 3 quarterly filings, Adaptive Biotechnologies Corp is an active lobbying client. Their lobbying covers 3 issue areas.

$10K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$10K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Adaptive Biotechnologies Corp disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Medicare/Medicaid

H.R. 1428, The VALID Act NIH Appropriations

HR2471 Appropriations for NIH for T cell research in COVID19 and other disease areas; HR4128 and S2209 The VALID Act. Provisions related to first of a kind assays

2023 appropriations requests for NIH for T cell research in COVID19 and other disease areas; HR4128 and S2209 The VALID Act. Provisions related to first of a kind assays

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.